Heron療法 HRTX 深 滬
等待開盤 01-30 09:30:00 美东时间
1.33
0.000
0.00%
華盛通- 最 高1.3488
- 今 開1.33
- 成交量 26.13万股
- 最 低 1.31
- 昨 收 1.33
- 總市值 2.43亿
- 52周最高 2.68
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 0.9999
- 委 比 -51.82%
- 總股本 1.83亿
- 歷史最高 42.90
- 量 比 1.16
- 振 幅 2.92%
- 歷史最低 0.16
- 每 手 1
- 風險率 0.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
HC Wainwright & Co. Reiterates Buy on Heron Therapeutics, Maintains $6 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $6 price target.
01-10 00:35
Heron Therapeutics Reports Q4 Preliminary Net Revenue Of ~$40.5M, ~$154.9M For 2025
Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth quarter and full-year 2025 net revenue.Net revenue of
01-09 22:31
Heron Therapeutics Includes APONVIE Injectable Emulsion In Guidelines For Postoperative Nausea, Vomiting
Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the inclusion of APONVIE® (aprepitant) injectable emulsion in the newly released Fifth
2025-12-04 21:17
Heron Therapeutics Affirms FY2025 Sales Guidance of $153.000M-$163.000M vs $156.482M Est
Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.000 million-$163.000 million to $153.000 million-$163.000 million vs $156.482 million estimate.
2025-11-04 21:03
Heron Therapeutics Q3 EPS $(0.10) Misses $(0.01) Estimate, Sales $38.213M Miss $39.031M Estimate
Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 233.33 percent decrease over losses of $(0.03) per share
2025-11-04 21:02
Heron Therapeutics Appoints Thomas Cusack to Board
Heron Therapeutics ( ($HRTX) ) has issued an update. On October 27, 2025, Heron...
2025-10-30 04:48
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Heron Therapeutics will hold a conference call and webcast on November 4, 2025, at 8:30 a.m. ET to discuss Q3 2025 financial results and recent business highlights. Participants can access the call via a registration link or through Heron's website under the Investor Relations section. An archive will be available post-call. Heron is a biotech company focused on improving patient care through innovative therapeutic developments.
2025-10-21 20:20
Heron Therapeutics Approves Stock Issuance Proposals
Heron Therapeutics ( ($HRTX) ) has issued an announcement. On October 13, 2025,...
2025-10-16 04:29
Heron Therapeutics Signs New Headquarters Lease
Heron Therapeutics ( ($HRTX) ) has shared an update. Heron Therapeutics, Inc. h...
2025-08-29 05:30
